Maternal and Child Health Field-Initiated Innovative Research Studies (FIRST) Program

Funding Agency:
Health Resources and Services Administration

This notice announces the opportunity to apply for funding under the R40 Maternal and Child Health (MCH) Field-Initiated Innovative Research Studies (FIRST) Program. The purpose of the MCH FIRST Program is to advance the health and well-being of MCH populations by supporting innovative, applied, and translational intervention1 research studies on critical issues affecting MCH populations. The research findings of the R40 MCH FIRST Program should be generalizable to the broader U.S. population, and of regional and national significance. 

The FY 2020 President’s Budget does not request funding for this program. This notice is a contingency action taken to ensure that, should funds become available for this purpose, HRSA can process applications and award funds in a timely manner. You should note that this program may be cancelled prior to award.

Deadline: Nov. 12, 2019

Agency Website

Eligibility Requirements

Only domestic public or non-profit institutions of higher learning and public or private non-profit agencies engaged in research or in programs relating to maternal and child health and/or services for children with special health care needs are eligible to apply (42 CFR § 51a.3(b)). Domestic faith-based and community-based organizations, tribes, and tribal organizations are eligible to apply.

NOTE: Multiple applications from an organization with the same DUNS number are allowable if the applications propose separate and distinct projects. For example, different investigators (or research teams) from the same institution can apply for the same NOFO. 

Amount

$900,000

Amount Description

HRSA expects approximately $900,000 to be available annually to fund three recipients. You may apply for a ceiling amount of up to $300,000 total cost (includes both direct and indirect, facilities and administrative costs) per year. The FY 2020 President’s Budget does not request funding for this program. The actual amount available will not be determined until enactment of the final FY 2020 federal appropriation. This program notice is subject to the appropriation of funds, and is a contingency action taken to ensure that, should funds become available for this purpose, HRSA can process applications and award funds in a timely manner. The period of performance is July 1, 2020 through June 30, 2023 (3 years). Funding beyond the first year is subject to the availability of appropriated funds for the R40 MCH FIRST Program in subsequent fiscal years, satisfactory recipient performance, and a decision that continued funding is in the best interest of the Federal Government.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

November 12, 2019